142 related articles for article (PubMed ID: 15101817)
1. Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis.
Ribichini F; Ferrero V; Matullo G; Feola M; Vado A; Camilla T; Guarrera S; Carturan S; Vassanelli C; Uslenghi E; Piazza A
Clin Sci (Lond); 2004 Oct; 107(4):381-9. PubMed ID: 15101817
[TBL] [Abstract][Full Text] [Related]
2. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction.
Samani NJ; O'Toole L; Martin D; Rai H; Fletcher S; Lodwick D; Thompson JR; Morice AH; Channer K; Woods KL
J Am Coll Cardiol; 1996 Aug; 28(2):338-44. PubMed ID: 8800107
[TBL] [Abstract][Full Text] [Related]
3. ACE gene polymorphism and coronary restenosis.
Bauters C; Amouyel P; Bertrand ME
Semin Interv Cardiol; 1999 Sep; 4(3):145-9. PubMed ID: 10545620
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease.
Beohar N; Damaraju S; Prather A; Yu QT; Raizner A; Kleiman NS; Roberts R; Marian AJ
J Investig Med; 1995 Jun; 43(3):275-80. PubMed ID: 7614074
[TBL] [Abstract][Full Text] [Related]
6. Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis.
Bauters C; Amouyel P
Eur Heart J; 1998 Sep; 19 Suppl J():J24-9. PubMed ID: 9796837
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
8. The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty.
Völzke H; Hertwig S; Rettig R; Motz W
Clin Sci (Lond); 2000 Jul; 99(1):19-25. PubMed ID: 10887054
[TBL] [Abstract][Full Text] [Related]
9. ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension.
Makris TK; Stavroulakis GA; Dafni UG; Gialeraki AE; Krespi PG; Hatzizacharias AN; Tsoukala CG; Vythoulkas JS; Kyriakidis MK
Am Heart J; 2000 Nov; 140(5):760-5. PubMed ID: 11054622
[TBL] [Abstract][Full Text] [Related]
10. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.
Cambien F; Poirier O; Lecerf L; Evans A; Cambou JP; Arveiler D; Luc G; Bard JM; Bara L; Ricard S
Nature; 1992 Oct; 359(6396):641-4. PubMed ID: 1328889
[TBL] [Abstract][Full Text] [Related]
11. The D-allele of the ACE polymorphism is related to increased QT dispersion in 609 patients after myocardial infarction.
Jeron A; Hengstenberg C; Engel S; Löwel H; Riegger GA; Schunkert H; Holmer S
Eur Heart J; 2001 Apr; 22(8):663-8. PubMed ID: 11286523
[TBL] [Abstract][Full Text] [Related]
12. [A study on angiotensin-I converting enzyme polymorphism in CAPD patients].
Nishina M
Nihon Jinzo Gakkai Shi; 1996 Dec; 38(12):595-602. PubMed ID: 9014479
[TBL] [Abstract][Full Text] [Related]
13. Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin 1-converting enzyme.
Sharma P; Carter ND; Barley J; Brown MM
J Hum Hypertens; 1994 Aug; 8(8):645-8. PubMed ID: 7990103
[TBL] [Abstract][Full Text] [Related]
14. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
[TBL] [Abstract][Full Text] [Related]
15. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement.
Koch W; Kastrati A; Mehilli J; Böttiger C; von Beckerath N; Schömig A
Circulation; 2000 Jul; 102(2):197-202. PubMed ID: 10889131
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis.
Ryu SK; Cho EY; Park HY; Im EK; Jang YS; Shin GJ; Shim WH; Cho SY
Yonsei Med J; 2002 Aug; 43(4):461-72. PubMed ID: 12205735
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting.
Ribichini F; Wijns W; Ferrero V; Matullo G; Camilla T; Feola M; Guarrera S; Vado A; Piazza A; Uslenghi E
Am J Cardiol; 2003 Jan; 91(2):154-8. PubMed ID: 12521626
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease.
Evans AE; Poirier O; Kee F; Lecerf L; McCrum E; Falconer T; Crane J; O'Rourke DF; Cambien F
Q J Med; 1994 Apr; 87(4):211-4. PubMed ID: 8208911
[TBL] [Abstract][Full Text] [Related]
19. Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to cardiovascular disease?
Bondy B; Baghai TC; Zill P; Bottlender R; Jaeger M; Minov C; Schule C; Zwanzger P; Rupprecht R; Engel RR
Mol Psychiatry; 2002; 7(10):1120-6. PubMed ID: 12476328
[TBL] [Abstract][Full Text] [Related]
20. Hypothesis: an angiotensin converting enzyme genotype, present in one in three caucasians, is associated with increased mortality rate.
Morris BJ
Clin Exp Pharmacol Physiol; 1996 Jan; 23(1):1-10. PubMed ID: 8713489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
